Latest Impairments News

Peak Processing delivered its first positive Group EBITDA quarter in FY2026, but the turnaround remains financially fragile. The ASX-listed THC beverage manufacturer reported a $7.8 million statutory loss, negative operating cash flow and an explicit material uncertainty over its ability to continue as a going concern.

Pure Foods Tasmania has warned of a material uncertainty over its ability to continue as a going concern after reporting an $8.6 million FY2026 loss, negative cash and a breach of its Commonwealth Bank covenant. The company expects its existing funding facilities to fall short from approximately February 2027, with further equity funding still uncommitted.

MC Mining has warned of a material uncertainty over its ability to continue as a going concern, despite its flagship Makhado project entering hot commissioning. The company ended FY2026 with US$2.904 million in cash, a US$49.746 million net current liability position and continued reliance on shareholder funding.

Gold Mountain expanded its Brazilian rare earths portfolio during FY2026, taking Irajuba beyond its original conceptual target and confirming ionic adsorption clay characteristics at Capivara. The progress came alongside an $8.137 million loss, a $4.798 million impairment charge and continued reliance on equity funding.

Vantage Metals has reported high-grade silver-zinc-copper-gold intersections in Argentina, but the exploration win sits alongside a A$26.7 million impairment and a material uncertainty over its ability to continue as a going concern. The company ended June with A$2.5 million in cash and remains reliant on further funding.

Magnetite Mines has warned that its existing cash is insufficient to fund planned activities for the next 12 months, while auditors highlighted a material uncertainty over the company’s ability to continue as a going concern. The ASX-listed miner is cutting costs and reshaping Razorback around a lower-capital development pathway.

Koonenberry Gold posted a sharply wider FY2026 loss after impairing its namesake project, while exploration spending rose and Enmore drilling extended a gold system to depth. The company has since raised $3.78 million from a placement, but remains dependent on equity funding.

Radiopharm Theranostics reported a A$56.3 million comprehensive loss for fiscal 2026, with operating cash outflows rising to A$52.8 million and cash falling to A$4.1 million. The company says further funding is required, while auditors flag a material uncertainty over its ability to continue as a going concern.

Decidr AI Industries delivered 99% revenue growth and a A$13.6 million annualised exit rate in FY26, but the company’s A$32.4 million loss and auditor-highlighted going concern uncertainty put funding at the centre of its next chapter. Management is targeting A$5 million in annualised savings while seeking to convert early AI deployments into recurring revenue.

Infotrust has completed a sweeping reshaping of its business, exiting Cloud and Communications, repaying $27 million in bank debt and acquiring Canberra cyber specialist Catalyst Cyber. The balance-sheet reset leaves the ASX-listed group targeting more than $6 million in FY27 underlying EBITDA, but its continuing business remains loss-making and execution risks are plainly visible.

SOCO Corporation Ltd (ASX:SOC) reported a $6.35 million FY26 statutory loss after writing down its Axsym business, even as second-half revenue, margins and cash flow improved. The company enters FY27 with $9.5 million of contracted project value carried forward and a further $4 million secured since year-end.

Celsius Resources has reported a sharply wider FY2026 loss after impairing its disputed interest in the MCB copper-gold project, while an Equinaire credit bid has complicated ownership of the Philippine asset. The company is relying on a pending Opuwo sale, fresh financing and arbitration to keep its development strategy alive.